Circulating antibodies to the glomerular basement membrane (GBM) of the kidney have been detected by indirect immunofluorescence and, more recently, radioimmunoassays [1-41. Both techniques present some disadvantages: indirect immunofluorescence is of rather limited sensitivity and is dependent on a subjective evaluation of fluorescence intensity, whereas radioimmunoassays require radiolabeling of GBM, expensive radioactivity counters, and are subject to increasing restrictions on the handling and disposal of radioactive materials. In other antigen-antibody systems, these disadvantages have been obviated by the introduction of an enzyme-linked immunosorbent (or immunospecific) assay (ELISA), which maintains the sensitivity of radioimmunoassays and uses safe and stable reagents [51. For these reasons, we have investigated the use of ELISA as an alternative procedure to detect circulating anti-GBM antibodies. Prior to studies with human material and to make sure of an adequate supply of sera and kidney eluates, we have used the test to detect anti-GBM antibodies in sera from rats treated with mercuric chloride. It has been shown that Brown Norway (BN) rats injected with this chemical produce anti-GBM antibodies that are deposited in a linear fashion in the glomeruli of the kidney [6].
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Methods BN rats, obtained from Microbiological Associates (Walkersville, Maryland) and Charles River Laboratories (Wilmington, Massachusetts) were treated with mercuric chloride as previously described [6] . Direct immunofluorescence staining of the kidneys from these rats and indirect immunofluorescence staining using sera from the same rats were performed by the method of Sapin, Druet, and Druet [61. Antibodies bound to the basement membranes of kidneys from BN rats treated with mercuric chloride were eluted using low pH citrate buffer [7] .
Alkaline-phosphatase-conjugated rabbit anti-rat immunoglobulin was prepared according to the method of Engvall and Perlmann [8] using commercially available alkaline phosphatase (Sigma type VII, Sigma Chemical Co., St. Louis, Missouri) and the DEAE-purified immunoglobulin fraction of a rabbit antiserum to rat immunoglobulin prepared in our laboratory. Microtiter plates of various brands and lot numbers were coated with GBM prepared from pooled kidneys of normal BN, Buffalo, and DA/L rats using a modification of a method previously described [91 and solubilized with 8 M urea [3] . The protein concentration of the soluble fraction of the urea-treated GBM, as determined by the ratio of the absorbance at 280 nm to the absorbance at 260 nm, indicated that 8.8% of the lyophilized GBM was solubilized.
GBM was diluted to 10 g/ml in carbonate buffer (pH, 9.6), and 100 p.l of this suspension were added to each well of a 96-well microtiter plate. The plate was then incubated at 37° C for 3 hours and either used immediately or stored at 40 C. The optimal concentration of GBM used routinely (10 g/ml) was determined by checkerboard titration. Prior to the addition of test sera, the coated plates were washed for 10 mm with three washes of PBS (pH, 7.2) containing 0.05% Tween 20 (PBSTween; Sigma Chemical Co., St. Louis, Missouri). After washing, rat sera to be tested were added to the wells. All sera were examined in duplicate, using tenfold dilutions in PBS-Tween. One hundred microliters of the sera were incubated in the well of the microtiter plates for 30 mm at 37° C. The sera were then removed from the plates, which were washed for 10 mm with three changes of PBS-Tween. Following these washes, 100 iiof alkaline-phosphatase-conjugated rabbit anti-rat immunoglobulin, diluted 1:500 in PBS-Tween, were added to each well of the microtiter plate. The optimal concentration of this conjugate for routine use was initially determined by checkerboard titration. After an incubation of 30 mm at 37° C, the conjugated antirat immunoglobulin was removed, and the plate washed for 10 mm with three changes of PBS-Tween. One hundred microliters of a 1-mg/mI suspension of p-nitrophenyl phosphate (Phosphatase substrate, Sigma Chemical Co.) in carbonate buffer (pH, 9.6) were then added to each well. After a 45-mm incubation at room temperature, the absorbance at 405 nm (OD405) was determined in each well using a Titer-tek Multiskan (Flow Laboratories, McLean, Virginia).
To inhibit the binding of rat anti-GBM antibodies to the GBM-coated wells, 500 p.1 of a rat serum containing anti-GBM antibodies were preincubated with 25 p.1 of a 1-mg/ml solution of Mean value for undiluted sera. d One serum in this group could not be tested undiluted by ELISA due to its limited quantity. rat thyroglobulin or with 25 pA of PBS. The sera were then assayed for anti-GBM by ELISA as described above.
Results
Detection of antibodies to GBM by direct and indirect immunofluorescence. Direct immunofluorescence on the kidneys obtained from treated rats 14 days after the first injection of mercuric chloride revealed intense linear staining of the GBM in 100% of these animals ( Table 1 ). No such staining was observed in kidney sections from untreated rats or control rats injected with acidic distilled water alone or saline. When a scale ranging from minus (-) (no fluorescence above background) to 4+ (extremely bright fluorescence) was used to provide a rough quantitation of fluorescence intensity, the kidneys from mercuric chloride-treated rats uniformly presented a 3 + or 4+ staining.
Indirect immunofluorescence proved insufficiently sensitive to detect circulating antibodies to GBM, because 11 of 20 sera from mercunc-chloride-treated rats did not stain the GBM (Table 1 ). The remaining sera were weakly positive, and none of them gave fluorescence staining over a 2+ intensity. Titers of the positive sera ranged from 5 to 20.
Detection of antibodies to GBM by ELISA. As shown in Table 1 , a total of 37 BN sera were tested by ELISA, 20 of them obtained from mercuric-chloride-treated rats and 17 from control animals. The highest 0D405 in the ELISA for any control serum was 0.068 (Fig. 1A) ; therefore, the 0D405 of 0.070 was chosen as the level above which any reading was considered positive. Using this criterion, 19 out of 19 sera from mercuricchloride-treated rats, when tested undiluted, were positive for anti-GBM antibodies (Fig. 1B) . The 0D405 values of these sera ranged from 0.081 to 0.355 with a mean of 0.190 and an SEM of 0.018. Thus, we were able to detect by ELISA circulating anti-GBM in 100% of the sera from the experimental animals, as compared with 45% by indirect immunofluorescence. When sera were diluted tenfold, 70% of the mercuric-chloride-treated animals remained positive for circulating anti-GBM although the mean 0D405 for these sera dropped to 0.090 with an SEM of 0.007. Only 20% of the treated sera remained positive at a onehundredfold dilution and none were positive after being diluted 1:1000. Titers of the sera containing anti-GBM antibodies ranged from 5 to 700, most of them between 10 and 100. It should be noted that sera from animals injected with acidic distilled water or neutral saline were negative for anti-GBM antibodies in indirect immunofluorescence and by ELISA.
Their kidneys were also negative by direct immunofluorescence ( Table 1) .
Specificity of ELISA for anti-GBM antibodies. As may be seen in Fig. 2 , preincubation of anti-GBM serum with GBM resulted in a substantial reduction of the anti-GBM activity in the serum as detected by ELISA. Preincubation with rat thyroglobulin produced only a slight reduction (6%) in the anti-GBM activity, possibly due to some nonspecific binding to the polystyrene tubes during the preincubation process. When compared with the ELISA reactions of serum preincubated with thyroglobulin or with PBS alone, the reaction of serum preincubated with GBM was reduced by 81% and 82%, respectively.
Studies of kidney eluates. The material eluted from the kidneys of mercuric-chloride-treated rats contained only rat IgG as determined by precipitation in agar and immunoelectrophoresis. When tested by indirect immunofluorescence, the eluate stained normal rat kidney GBM with a 3+ intensity at a 1:5 dilution (with a protein content of 600 J.gIml) and with an endpoint at 1:160 (19 igIml). On the other hand, antibodies to GBM were still detected by ELISA at a dilution of 1:1000 (0.06 g!ml).
Discussion
When sera from mercuric-chloride-treated rats were tested by ELISA, we observed positive reactions in 100% of the animals. In contrast, only 45% were positive when tested by indirect immunofluorescence on cryostat sections of rat kidney. The titers of anti-GBM antibodies obtained by ELISA ranged between 5 and 700, whereas those obtained in indirect immunofluorescence were never above 20. Thus, ELISA proved to be much more sensitive than indirect immunofluorescence. The specificity of the reaction was clearly demonstrated by the fact that sera from control rats showed minimal binding to the GBM and by significant inhibition obtained when positive sera were preincubated with GBM. On the other hand, preincubation of the same sera with an unrelated antigen such as rat thyroglobulin did not cause any inhibition of the anti-GBM reaction.
Antibodies to GBM eluted from kidneys of mercuric-chloridetreated rats were similarly detected by ELISA. It was found that as little as 0.06 g/ml antibody protein were easily detectable.
The binding of GBM to microtiter plates varies between different brands and lot numbers. Other antigens of similar composition, such as bacterial polysaccharides, also coat ELISA plates in an irregular fashion [10-121. But, we have noticed that once a satisfactory lot of microtiter plates is identified and is used routinely, day-to-day reproducibility of this ELISA is extremely satisfactory. In addition, preliminary data indicate that collagenase-solubilized GBM [13, 141 retains sufficient antigenic sites for use in this ELISA system. Collagenase solubilization appears to facilitate binding of the GBM to microtiter plates more than urea solubilization does. Thus, the problem of unpredictability in coating different lots of plates may be solved by using the enzyme-solubilized GBM.
In conclusion, our study shows that ELISA may be used for the detection of anti-GBM antibodies in rats treated with 
